Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share...
1.1k Views
Concord Biotech (Pre-IPO): Niche Offering Amid Lean Competition to Drive Stable Growth
The IPO consists of offer for sale of 21M shares by Helix Investment Holdings at a price band of INR705ā741/share. Through this IPO, Concord seeks...
496 Views
Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind
Through capacity and capability addition in biologics manufacturing and expansion of commercial API manufacturing, Syngene has expanded...
507 Views
Diviās Laboratories - Miss in 2QFY23; Growth Factors to Face Softness over Medium Term
DIVI delivered an earnings miss in 2QFY23. Reduced traction in Custom Synthesis (CS), coupled with lower operating leverage resulted in an earnings...
484 Views
Piramal Enterprises (PIEL IN): Demerger to Create a Differentiated and Niche Pharmaceutical Business
Shareholdersā nod for the proposed demerger will create pharmaceutical-focused listed entity, which should pave the way for value unlocking due to...
518 Views